Nurse Practitioner in Port Deposit, MD Accepting Medicare
2 Nurse Practitioner nurses found. Showing 1 - 2
 Shenicka O'brien, NP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 20 Craigtown Rd, Port Deposit, MD 21904 Phone: 410-642-9472 |
Andrea Brooks, CRNP Nurse Practitioner - Acute Care Medicare: Accepting Medicare Assignments Practice Location: 401 Rowland Dr, Port Deposit, MD 21904 Phone: 978-289-7247 |
News Archive
Melanocyte-like cells in heart and pulmonary veins contribute to atrial fibrillation
The source and mechanisms underlying the abnormal heart beats that initiate atrial fibrillation (Afib), the most common type of abnormal heart beat, have not been well determined. However, a group of researchers at the University of Pennsylvania, Philadelphia, has now identified a population of cells that are like pigment producing cells in the skin (melanocytes) in the atria of the heart and pulmonary veins of mice and humans and uncovered evidence in mice that these cells contribute to Afib.
Specific biomarker predicts which HER2-negative breast cancer patients respond to targeted therapy
A multicenter team led by Case Western Reserve has demonstrated that brief exposure to a targeted therapy can tell doctors which HER2-negative patients will respond — and which should switch to another kind of treatment.
Britain, Australia urge international community to assist in drought relief
Andrew Mitchell, Britain's international development secretary, and Kevin Rudd, Australia's foreign minister, describe their countries' responses to the drought and famine in East Africa in an Independent opinion piece.
Scientists identify potential treatment for previously unknown condition affecting children
Researchers from the Agency for Science, Technology and Research's (A*STAR) Genome Institute of Singapore (GIS), and Rady Children's Institute for Genomic Medicine identified a previously unknown condition affecting children, which they discovered could be prevented by administering a drug during pregnancy.
Alexza receives notification letter regarding noncompliance with NASDAQ listing rule
Alexza Pharmaceuticals, Inc. announced today that on December 17, 2015, the Company received a letter from the Nasdaq Staff indicating that the Company had not regained compliance with the $35 million market capitalization requirement for continued listing on The Nasdaq Capital Market by the end of the previously granted compliance period, which expired on December 16, 2015.
› Verified 2 days ago